{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:06:07Z","timestamp":1786993567754,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3600504"],"award-info":[{"award-number":["2022YFC3600504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtha.2025.02.017","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:01:13Z","timestamp":1740398473000},"page":"1676-1688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Navigating the waters of acute minor stroke therapies: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1376-3484","authenticated-orcid":false,"given":"Xuefan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aini","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-3894","authenticated-orcid":false,"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.02.017_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/STROKEAHA.123.045495","article-title":"Intravenous alteplase versus best medical therapy for patients with minor stroke: a systematic review and meta-analysis","volume":"55","author":"Zhang","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.56.8.1015","article-title":"Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility","volume":"56","author":"Barber","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2025.02.017_bib3","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/01.STR.0000185798.78817.f3","article-title":"Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib4","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/STROKEAHA.116.014871","article-title":"Baseline predictors of poor outcome in patients too good to treat with intravenous thrombolysis","volume":"47","author":"Ali","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/STROKEAHA.115.011528","article-title":"Distinct short-term outcomes in patients with mild versus rapidly improving stroke not treated with thrombolytics","volume":"47","author":"Romano","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib6","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.3760\/cma.j.issn.0366-6999.20130634","article-title":"Neurological deterioration in the acute phase of minor ischemic stroke is an independent predictor of poor outcomes at 1 year: results from the China National Stroke Registry (CNSR)","volume":"126","author":"Ju","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jtha.2025.02.017_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jamaneurol.2014.4354","article-title":"Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry","volume":"72","author":"Romano","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2025.02.017_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1747493015620805","article-title":"European Cooperative Acute Stroke Study-4: extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND","volume":"11","author":"Amiri","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.02.017_bib10","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/STROKEAHA.115.009951","article-title":"Effect of intravenous recombinant tissue-type plasminogen activator in patients with mild stroke in the third international stroke trial-3: post hoc analysis","volume":"46","author":"Khatri","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib11","article-title":"Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke","volume":"4","author":"Choi","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.02.017_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/svn-2017-000106","article-title":"Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis","volume":"3","author":"You","year":"2018","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jtha.2025.02.017_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.29271\/jcpsp.2022.03.352","article-title":"Intravenous alteplase treatment of acute ischemic stroke patients exhibiting mild neurological deficits","volume":"32","author":"Sun","year":"2022","journal-title":"J\u00a0Coll Physicians Surg Pak"},{"key":"10.1016\/j.jtha.2025.02.017_bib14","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.04.008","article-title":"Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis","volume":"23","author":"Yeo","year":"2014","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2025.02.017_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1398","article-title":"Reperfusion therapy for minor stroke: a systematic review and meta-analysis","volume":"9","author":"Lan","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.jtha.2025.02.017_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/23969873241237312","article-title":"Intravenous alteplase in minor nondisabling ischemic stroke: a systematic review and meta-analysis","volume":"9","author":"Alhazzani","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jtha.2025.02.017_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11239-024-02994-z","article-title":"Dual antiplatelet therapy vs alteplase in adult patients with acute minor ischemic stroke: a systematic review and meta-analysis","volume":"57","author":"Viana","year":"2024","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.02.017_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107704","article-title":"Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: a systematic review and meta-analysis of safety and efficacy","volume":"33","author":"Abbas","year":"2024","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2025.02.017_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Int Emerg Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.02.017_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jtha.2025.02.017_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib23","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the modified Rankin scale and its use in future stroke trials","volume":"48","author":"Broderick","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib24","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin scale global disability outcomes: consensus recommendations from Stroke Therapy Academic Industry Roundtable XI","volume":"52","author":"Saver","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib25","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jtha.2025.02.017_bib28","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.02.017_bib29","first-page":"1","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jtha.2025.02.017_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jtha.2025.02.017_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jtha.2025.02.017_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12874-021-01397-5","article-title":"Predictive P-score for treatment ranking in Bayesian network meta-analysis","volume":"21","author":"Rosenberger","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jtha.2025.02.017_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2025.02.017_bib34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.02.017_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12874-020-01075-y","article-title":"The statistical importance of a study for a network meta-analysis estimate","volume":"20","author":"R\u00fccker","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jtha.2025.02.017_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.12688\/f1000research.14770.1","article-title":"Estimating the contribution of studies in network meta-analysis: paths, flows and streams","volume":"7","author":"Papakonstantinou","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jtha.2025.02.017_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.jtha.2025.02.017_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib42","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.jtha.2025.02.017_bib43","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1136\/ebmental-2022-300457","article-title":"Vitruvian plot: a visualisation tool for multiple outcomes in network meta-analysis","volume":"25","author":"Ostinelli","year":"2022","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jtha.2025.02.017_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.02.017_bib45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/STROKEAHA.119.027465","article-title":"Disability after minor stroke and transient ischemic attack in the POINT trial","volume":"51","author":"Cucchiara","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11239-019-02001-w","article-title":"\u201cMinor\u201d stroke: not a minor, still open question","volume":"49","author":"Rota","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.02.017_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/svn-2019-000319","article-title":"Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jtha.2025.02.017_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.02.017_bib49","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/cns.14124","article-title":"Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion","volume":"29","author":"Duan","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jtha.2025.02.017_bib50","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1212\/WNL.0000000000207538","article-title":"IV Thrombolysis vs early dual antiplatelet therapy in patients with mild noncardioembolic ischemic stroke","volume":"101","author":"Sykora","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2025.02.017_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107203","article-title":"Factors related to unfavorable outcome in minor ischemic stroke","volume":"32","author":"Ton","year":"2023","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2025.02.017_bib52","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/svn-2023-002828","article-title":"Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial","volume":"9","author":"Nair","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jtha.2025.02.017_bib53","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.jtha.2025.02.017_bib54","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib56","article-title":"Tenecteplase, 0.4 mg\/kg, in moderate and severe acute ischemic stroke: a pooled analysis of NOR-TEST and NOR-TEST 2A","volume":"12","author":"Novotny","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.02.017_bib57","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jrsm.1084","article-title":"Empirical evaluation of meta-analytic approaches for nutrient and health outcome dose-response data","volume":"4","author":"Yu","year":"2013","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jtha.2025.02.017_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0163278708324438","article-title":"Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses","volume":"31","author":"Peters","year":"2008","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.jtha.2025.02.017_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1358863X241265335","article-title":"Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials","volume":"29","author":"Ahmed","year":"2024","journal-title":"Vasc Med"},{"key":"10.1016\/j.jtha.2025.02.017_bib60","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"Mendelson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.02.017_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaneurol.2021.4514","article-title":"Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis","volume":"79","author":"Lun","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2025.02.017_bib62","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1160\/TH04-12-0795","article-title":"Circulating endothelial cells in acute ischaemic stroke","volume":"94","author":"Nadar","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.02.017_bib64","doi-asserted-by":"crossref","first-page":"LXI","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jtha.2025.02.017_bib65","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/00912700022009125","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction","volume":"40","author":"Modi","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jtha.2025.02.017_bib66","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/STROKEAHA.122.042335","article-title":"Complications of intravenous tenecteplase versus alteplase for the treatment of acute ischemic stroke: a systematic review and meta-analysis","volume":"54","author":"Rose","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/bc.bc_70_22","article-title":"Intravenous thrombolysis for acute ischemic stroke: from alteplase to tenecteplase","volume":"9","author":"Yang","year":"2023","journal-title":"Brain Circ"},{"key":"10.1016\/j.jtha.2025.02.017_bib68","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209903","article-title":"Tenecteplase vs alteplase in acute ischemic stroke within 4.5 hours: a systematic review and meta-analysis of randomized trials","volume":"103","author":"Palaiodimou","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2025.02.017_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.02.017_bib70","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","article-title":"Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial","volume":"403","author":"Coutts","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.02.017_bib71","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/STROKEAHA.110.593897","article-title":"Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke","volume":"43","author":"Khatri","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib72","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s10072-023-06801-0","article-title":"The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis","volume":"44","author":"Wei","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jtha.2025.02.017_bib73","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.02.017_bib74","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000339675","article-title":"Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions","volume":"34","author":"Seet","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2025.02.017_bib75","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/STROKEAHA.109.554386","article-title":"Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials","volume":"40","author":"Cucchiara","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1747-4949.2012.00808.x","article-title":"Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms","volume":"8","author":"Strbian","year":"2013","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib77","first-page":"61","article-title":"Perfusion and diffusion variables predict early neurological deterioration in minor stroke and large vessel occlusion","volume":"23","author":"Gwak","year":"2021","journal-title":"J\u00a0Stroke"},{"key":"10.1016\/j.jtha.2025.02.017_bib78","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3174\/ajnr.A1000","article-title":"An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale","volume":"29","author":"Torres-Mozqueda","year":"2008","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:58:25Z","timestamp":1777618705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1538783625001151"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.017","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the waters of acute minor stroke therapies: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}